网站首页  词典首页

请输入您要查询的英文单词:

 

单词 bortezomib
释义

bortezomib

  • 网络硼替佐米;万珂;蛋白酶体抑制剂硼替佐米
1.
硼替佐米
  硼替佐米Bortezomib)是一种蛋白酶体抑制剂,可用于多发性骨髓瘤的治疗。近来,在转基因小鼠体内的研究证实,硼替佐 …
www.cmt.com.cn
2.
万珂
第二部分万珂(Bortezomib)与美罗华(Rituximab)和环磷酰胺(Cyclophosphamide)体内、外协同诱导套细胞淋巴瘤细胞凋亡机制 …
cdmd.cnki.com.cn
3.
蛋白酶体抑制剂硼替佐米
  实验显示蛋白酶体抑制剂硼替佐米(bortezomib)抑制瘤细胞的增殖和诱导凋亡的主要机制是通过特异性抑制蛋白酶体26S亚基, …
xy.39.net
4.
硼替左米
...癌的西妥昔单抗(Cetuximab)、治疗骨髓瘤的硼替左米Bortezomib),以及治疗恶性胸膜间皮瘤的培美曲塞(Pemetrexed…
sc.isd.gov.hk
5.
硼替佐咪
硼替佐咪bortezomib)是一种人工合成的蛋白酶体竞争性抑制剂,对复发难治的MM有显著疗效。硼替佐咪的主要生物学效应 …
www.qqyy.com
6.
硼体佐米
硼体佐米(bortezomib)是第一个用于治疗多发性骨髓瘤的蛋白酶体抑制剂,研究发现其对MCL也非常有效。Goy等〔27〕用硼体 …
www.gzbaozhilin.com
7.
硼替唑咪
已经上市的分子靶向药物_好大夫在线 ... Velcade( 万珂) Bortezomib硼替唑咪) Lapatinib( 拉帕替尼) ...
www.haodf.com

例句

释义:
1.
Results Bortezomib can be a time and dose dependent manner inhibited the growth of DC.
结果:硼替佐米能够以时间、剂量依赖方式抑制DC的生长。
www.yixue360.com
2.
Conclusion: Bortezomib alone or in combination with irinotecan was not effective in patients with relapsed or refractory CRC.
结论:单用硼替佐米或联合伊立替康对复发或耐药的结直肠癌无效。
www.doctorsky.cn
3.
A lot of reports suggested that bortezomib had a significant effect in treatment of multiple myeloma in out country.
国内有许多关于硼替佐米治疗多发性骨髓瘤临床疗效的研究报道指出其疗效显著。
pp.lunwenchina.net.cn
4.
With the application of time, bortezomib was extended continuously.
随着应用时间的延长,硼替佐米不断被推广。
pp.lunwenchina.net.cn
5.
The history of brought bortezomib in clinical and used it for multiple myeloma treatment is about 5 years.
我国医疗界将硼替佐米应用于临床,用于治疗多发性骨髓瘤的历史大约5年。
pp.lunwenchina.net.cn
6.
The hazard ratio for overall survival was 0. 61 for the bortezomib group (P=0. 008).
硼替佐米组的总生存期的危险比率为0.61(P=0.008)。
www.dxy.cn
7.
To study the effects of bortezomib on the cell adhesion and the cell adhesion mediated adriamycin resistance of RPMI8226 cells.
研究硼替佐米对黏附介导骨髓瘤细胞的阿霉素耐药逆转作用。
www.fabiao.net
8.
Salvage Therapy with Proteasome Inhibitor Bortezomib for Relapsed and Refractory Multiple Myeloma
蛋白酶体抑制剂硼酸盐二肽治疗难治性多发性骨髓瘤
www.ilib.cn
9.
The proportions of patients with a partial response or better were 71% in the bortezomib group and 35% in the control group;
部分缓解或更好反应的患者比例,硼替佐米组为71%,而对照组为35%的;
news.dxy.cn
10.
Clinical Progress on Bortezomib in the Treatment for Multiple Myeloma
硼替佐米治疗多发性骨髓瘤临床应用进展
www.ilib.cn
1.
Induction of Apoptosis in HL-60 Cells by Bortezomib alone or in Combination with Harringtonine In Vitro
硼替佐米单用或联合三尖杉酯碱体外诱导HL-60细胞凋亡实验研究
www.ilib.cn
随便看

 

英汉双解词典包含2704715条英汉词条,基本涵盖了全部常用单词的翻译及用法,是英语学习的有利工具。

 

Copyright © 2004-2022 Newdu.com All Rights Reserved
更新时间:2025/2/28 20:45:20